Effects of hearing intervention on blood-based biomarkers of neuroinflammation and neurodegeneration: a secondary analysis of the ACHIEVE randomised controlled trial

This publication has 26 references indexed in Scilit:

• Audiometric hearing and plasma biomarkers of Alzheimer's disease pathology and neurodegeneration in the Atherosclerosis Risk in Communities Neurocognitive Study
  Alzheimer's & Dementia, 2025
• Plasma NfL and GFAP in the preclinical stages of neurodegenerative diseases: insights from the UK Biobank
  Journal of Neurology, 2025
• Body mass index and blood volume influence plasma biomarkers and positron emission tomography classification in preclinical Alzheimer's disease
  Alzheimer's & Dementia, 2025
• Hearing Intervention, Social Isolation, and Loneliness
  JAMA Internal Medicine, 2025
• Association between adult-onset hearing loss and dementia biomarkers: A systematic review
  Ageing Research Reviews, 2024
• Microglia measured by TSPO PET are associated with Alzheimer's disease pathology and mediate key steps in a disease progression model
  Alzheimer's & Dementia, 2024
• Age-related hearing loss is not linked to cerebrospinal fluid levels of β-amyloid or p-tau181
  Neurological Sciences, 2023
• The ARIC (Atherosclerosis Risk In Communities) Study
  JACC, 2021
• Axon–glia interactions in the ascending auditory system
  Developmental Neurobiology, 2021
• Association of Age-Related Hearing Loss With Cognitive Function, Cognitive Impairment, and Dementia
  JAMA Otolaryngology–Head & Neck Surgery, 2018